|
|
|
|
|||||
|
|
|
Chicago, IL – August 14, 2025 – Stocks in this week’s article are Modine Manufacturing Co. MOD, Tutor Perini Corp. TPC, Kiniksa Pharmaceuticals International plc KNSA, Life360 Inc. LIF and Euroseas Ltd. ESEA.
U.S. stock markets have maintained their northward journey in the first half of August despite tariff and trade-related uncertainties and the Fed's indecision regarding the timing of the first interest rate cut in 2025.
The Trump administration is yet to enter into trade deals with several key trading partners of the United States including China. On the other hand, despite an overwhelming market expectation of a 25-basis point rate cut in September, the central bank has yet to indicate anything in that direction. In this regard, the outcome of the Fed's annual Jackson Hole Symposium for Economic Policies, to be held during Aug 21-23 will be of utmost importance.
Consequently, very few stocks have shown price strength. We have primarily targeted stocks that have recently been on a bull run. Such stocks have a high chance of carrying the momentum forward.
Five such stocks are — Modine Manufacturing Co., Tutor Perini Corp., Kiniksa Pharmaceuticals International plc, Life360 Inc. and Euroseas Ltd..
If a stock is continuously witnessing an uptrend, there must be a solid reason or it would have probably crashed. So, looking at stocks capable of beating the benchmark that they have set for themselves seems rational.
However, recent price strength alone cannot create magic. Therefore, other relevant parameters are needed to create a successful investment strategy.
Here's how you should create the screen to shortlist the current as well as the potential winners.
Let's discuss five out of these eight stocks here:
Modine Manufacturing designs, engineers, tests, manufactures, and sells mission-critical thermal solutions in the United States, Canada, Italy, Hungary, the United Kingdom, China and internationally. MOD operates through the Climate Solutions and Performance Technologies segments.
MOD's products include heat exchangers for cooling all types of engines, transmissions, auxiliary hydraulic equipment, air conditioning components used in cars, trucks, farm and construction machinery and equipment, and heating and cooling equipment for residential and commercial building HVAC (heating, ventilating, air conditioning and refrigeration equipment).
The stock price of Modine Manufacturing has soared 46.1% over the past four weeks. It has an expected earnings growth rate of 14.3% for the current year (ending March 2026). The Zacks Consensus Estimate for current-year earnings has improved 1.1% over the last seven days.
Tutor Perini provides diversified general contracting, construction management and design-build services to private clients and public agencies worldwide. TPC operates in four segments: Civil, Building, Specialty Contractors, and Management Services. The Civil segment is engaged in public works construction activities and the repair, replacement, and reconstruction of infrastructure.
The Building segment of TPC offers services in specialized building markets, including hospitality and gaming, transportation, healthcare, municipal offices, sports and entertainment, education, correctional facilities, biotech, pharmaceutical, industrial, and high technology.
The Specialty Contractors segment provides plumbing, HVAC, electrical, mechanical, and concrete services for the industrial, commercial, hospitality and gaming, and transportation markets. TPC's Management Services segment offers construction and design-build services to the U.S. military and government agencies, and multi-national corporations.
The stock price of Tutor Perini has surged 14.3% in the past four weeks. It has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 56.3% over the last seven days.
Kiniksa Pharmaceuticals International is a biopharmaceutical company, focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide.
KNSA focuses on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs.
The stock price of KNSA has climbed 13.7% in the past four weeks. The company has expected earnings growth of more than 100% for the current year. The Zacks Consensus Estimate for the current year has improved more than 9.6% over the last seven days.
Life360 operates a technology platform to locate people, pets, and things in North America, Europe, the Middle East, Africa, and internationally. LIF provides Life360 mobile application under the freemium model that offers communications, driving safety, digital safety, and location sharing. LIF's Life360 Platform provides location coordination and safety, driving safety, digital safety, and emergency assistance services; and mobile-first technology platform that protects members data and ensures integrity, security, and performance. LIF also offers place alerts, individual driver reports, crash detection, battery monitoring, SOS help alerts, family driving summary, and customer support.
The stock price of Life360 has advanced 8.3% over the past four weeks. The company has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 20.8% over the last 30 days.
Euroseas provides ocean-going transportation services worldwide. ESEA owns and operates containerships that transport dry and refrigerated containerized cargoes, including manufactured products and perishables. ESEA employs its vessels on spot and period charters and through pool arrangements.
The stock price of ESEA has gained 2.8% over the past four weeks. The company has an expected earnings growth rate of 4% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 2.8% over the last 30 days.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2706779/5-stocks-with-recent-price-strength-amid-trade-rate-cut-uncertainties
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Follow us on Twitter: https://www.twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: [email protected]
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| 2 hours | |
| 3 hours | |
| Aug-13 | |
| Aug-13 | |
| Aug-13 | |
| Aug-13 | |
| Aug-13 | |
| Aug-13 | |
| Aug-13 | |
| Aug-12 | |
| Aug-12 | |
| Aug-12 | |
| Aug-12 | |
| Aug-12 | |
| Aug-12 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite